Q12109 (Q12109): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Removed claims) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
| |||||||||||||||
| Property / EU contribution: 5,007,500.0 Czech koruna / rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
| |||||||||||||||
| Property / EU contribution: 200,300.0 Euro / rank | |||||||||||||||
| Property / EU contribution: 200,300.0 Euro / qualifier | |||||||||||||||
| |||||||||||||||
| Property / EU contribution: 200,300.0 Euro / qualifier | |||||||||||||||
| |||||||||||||||
| Property / budget | |||||||||||||||
| |||||||||||||||
| Property / budget: 10,015,000.0 Czech koruna / rank | |||||||||||||||
| Property / budget | |||||||||||||||
| |||||||||||||||
| Property / budget: 400,600.0 Euro / rank | |||||||||||||||
| Property / budget: 400,600.0 Euro / qualifier | |||||||||||||||
| |||||||||||||||
| Property / budget: 400,600.0 Euro / qualifier | |||||||||||||||
| |||||||||||||||
Revision as of 02:52, 12 February 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project in Czech Republic financed by DG Regio |
Statements
50 percent
0 references
30 June 2020
0 references
VUAB Pharma a.s.
0 references
50°9'46.91"N, 14°23'2.26"E
0 references
25263
0 references
Předkládaný projekt je zaměřen na rozšíření výzkumně-vývojového centra pro urychlení a zkvalitnění vývoje konečné lékové formy léčiv nádorových onemocnění, a to jak originálních, tak generických léčiv, které bylo vybudováno v předchozích letech. a. (Czech)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/17_165/0015953
0 references